“In 2005, the FDA granted approval for a promising new cancer-fighting drug called Nexavar. Bayer took it to market shortly thereafter, and it is currently an approved treatment for late-stage kidney and liver cancer.
That is, so long as you live in the developed world. In a recently published interview in Bloomberg Businessweek, Bayer CEO Marijn Dekkers said that his company’s drug isn’t for poor people.
“We did not develop this medicine for Indians…we developed it for western patients who can afford it,” he said back in December. The quote is quickly making its way across Indian news outlets.
Consumer Resources 